Nevoid Basal Cell Carcinoma Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-05-05
Clinical Trial Update: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating topical Hedgehog pathway inhibitor LDE225 cream for adults with nevoid basal cell carcinoma syndrome (NBCCS) an…